ZYXIQ
ZYNEX INC
Key Financials
Revenue
$192.4M
↑ 4.4%
Net Income
$3.0M
↓ 69.2%
Gross Profit
$13.5M
↓ 56.2%
Operating Income
$6.0M
↓ 44.4%
EPS (Diluted)
$0.09
↓ 66.7%
Total Assets
$122.1M
↓ 10.8%
Total Liabilities
$86.4M
↓ 4.9%
Cash & Equivalents
$13.3M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 3/27/2026 | View on SEC |
| 4 | 3/27/2026 | View on SEC |
| 4 | 3/27/2026 | View on SEC |
| 15-12G | 3/26/2026 | View on SEC |
| 8-K | 3/26/2026 | View on SEC |
| S-8 POS | 3/26/2026 | View on SEC |
| S-8 POS | 3/26/2026 | View on SEC |
| 8-K | 3/20/2026 | View on SEC |
| EFFECT | 3/18/2026 | View on SEC |
| RW | 3/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZYXIQ |
| Company Name | ZYNEX INC |
| CIK | 846475 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (800)-495-6670 |